Live
- Trump's WHO threat sparks debate on the efficiency of global health governance
- ICC Champions Trophy 2025 Schedule: India vs Pakistan Match Set for February 23 in Dubai
- Champions Trophy 2025: Full Schedule, Match Dates, Venues, Timings, and Updates
- FRAI Urges Government to Provide Technology Platform for Kirana Stores to Stay Competitive
- Not just Gen Z, millennials too: Redditors discuss the wave of pet parenthood embraced by young Indians
- Innovation can expedite the journey to a Smoke-Free future- in focus at Technovation Abu Dhabi
- Pramod Kumar Voola: Pioneering ethical AI and innovation in healthcare technology
- Rahul Vadisetty: Harnessing AI to revolutionize predictive healthcare
- Interview with Sukumar Bisetty: Driving business transformation with technology
- Kerala Man Arrested in Mangaluru for ₹10.84 Lakh Investment Scam
Natco Pharma Q2 net up 73% to Rs 204 crore
Natco Pharma Q2 net up 73% to Rs 204 crore
Drug firm Natco Pharma on Thursday reported a 73.23 per cent increase in its consolidated net profit to Rs 203.9 crore for the quarter ended September mainly on account of robust sales
Hyderabad: Drug firm Natco Pharma on Thursday reported a 73.23 per cent increase in its consolidated net profit to Rs 203.9 crore for the quarter ended September mainly on account of robust sales.
The company had posted a net profit of Rs 117.7 crore for the corresponding period of the previous fiscal, Natco Pharma said.
Consolidated total income of the company stood at Rs 827.9 crore for the quarter under consideration. It was Rs 518.9 crore for the same period a year ago, it added.
The board of directors has recommended a second interim dividend of Rs 3 per equity share of Rs 2 each for the financial year 2020-21. Shares of Natco Pharma were trading at Rs 902.00 per scrip on BSE, up 0.52 per cent from its previous close.
